REQUEST A DEMO
Total
USD $0.00
Search more companies

Propharma S. R. O. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Propharma S. R. O. Profile Updated: July 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

ProPharma Group provides regulatory, clinical, and compliance services for the life sciences industry. The company offers solutions for pharmaceutical, biotechnology, and medical device companies, including regulatory, clinical, and quality compliance services, medical writing, pharmacovigilance, and R&D technology. ProPharma Group specializes in providing expertise and tailored solutions across all stages of cell and gene therapy product development. The company has expertise in ISO 13485, 21 CFR part 820, and other global regulatory requirements for medical devices and diagnostics.

Headquarters
Na Bystricku, 796/9
Martin; Zilinsky; Postal Code: 03601

Contact Details: Purchase the Propharma S. R. O. report to view the information.

Website: http://www.propharmagroup.com/

Basic Information
Registered Capital:
Purchase the Propharma S. R. O. report to view the information.
Financial Auditors:
Purchase the Propharma S. R. O. report to view the information.
Incorporation Date:
May 03, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
53.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
13.33%
Company Performance
Financial values in the chart are available after Propharma S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Total operating revenue
-100%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
0.16%
Total equity
-0.54%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.1%
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?